As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Conagra Brands added a “GLP-1 Friendly” label to 26 of its Healthy Choice frozen meals in early 2025. The Smoothie King chain ...

Fox News senior medical analyst Dr. Marc Siegel discusses the benefits and risks of GLP-1 medications on 'Fox & Friends ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes for people who do develop the disease.

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

Novo, the maker of the obesity drug Wegovy, has repeatedly warned about the risks of compounded and knock-off versions of GLP ...

Weight loss drugs like Ozempic and Wegovy have had a meteoric rise in recent years, but how fast does the weight return after ...